Antibacterial Drugs Market 2015 World Analysis and Forecast to 2023 Antibacterial Drugs Market - Global Industry Analy

Antibacterial Drugs Market - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast 2015 – 2023
This report on antibacterial drugs market studies the current as well as future prospects of the market
globally. The market for antibacterial drugs is segmented on the basis of major classes of
drugs,namely,aminoglycosides,B-lactams, tetracyclines, sulfonamides, quinolones/fluoroquinolones,
macrolides, phenicols and miscellaneous antibacterials. The market for each of these classes has
been extensively analyzed on the basis of leading drug launch, patent expiry, drug efficacy, annual
sales revenue and geography wise regulatory approval. The market size and forecast in terms of USD
million for each of these classes has been provided for the period 2013 to 2023, considering 2013 and
2014 as the historical and base year respectively, while the market forecast has been provided for the
period 2015 to 2023. The report on antibacterial drugs market also provides compounded annual
growth rate (CAGR) for each market segment for the forecast period 2015 to 2023
This 110 page report gives readers a comprehensive overview of the Antibacterial Drugs market Browse
through 09 data tables and 40 figures to unlock the hidden opportunities in this market.
http://www.transparencymarketresearch.com/antibacterial-drugs-market.html
Geographically, the antibacterial drugs market has been categorized into five regions, namely, North
America, Europe, Asia Pacific, Latin America and Rest of the World (ROW). Each of these
geographies have been further segmented with respect to major countries; where North America is
segmented in U.S. and Canada, Europe is segmented in U.K., Germany and rest of Europe, Asia
Pacific is segmented in China, Japan and rest of Asia Pacific, and Latin America is segmented in Brazil
and rest of Latin America. The report also comprises a section on pipeline analysis, which provides
sales forecast for various drugs currently under phase III clinical trials and are expected to be launched
during the forecast period. Forecast of seventeen pipeline drugs has been provided since their launch
in the U.S., till 2023. Apart from the quantitative information, the report also provides details on various
qualitative factors impacting the antibacterial market trends such as drug recalls, black box warning,
changes in regulatory policies, drug patent expiry and subsequent launch of generics and others.
The research study also incorporates competitive scenario in the considered regions. A detailed
qualitative analysis of the factors responsible for driving and restraining growth of the global
antibacterial drugs market, and future opportunities has been provided in the market overview section.
This section of the report also provides detailed market attractiveness analysis for major geographies.
The analysis considers factors such as level of competition, interference of government and regulatory
agencies, available customer base and future potential. The global antibacterial drugs market report
includes a chapter on competitive landscape which provides market share analysis by leading players
in the antibacterial drugs market, in terms of percent share in the year 2014. The report also includes
event impact analysis, which provides a holistic view of new drug approvals in the market. A list of
recommendations has also been provided for new entrants as well as existing market players to help
them establish a strong presence in the market and increase their market share.